Stockholm - Delayed Quote SEK
Elicera Therapeutics AB (publ) (ELIC.ST)
At close: 5:29 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-27,738.1890
-14,922.5120
-8,570.8200
-14,293.1020
-905.2510
Investing Cash Flow
-1.0000
483.1700
--
-1.0000
-8.8800
Financing Cash Flow
20,479.3060
--
--
55,122.4530
12,445.0820
End Cash Position
32,864.6070
29,382.9670
43,822.3090
52,393.1290
11,564.7790
Capital Expenditure
--
-1.0000
--
--
-58.8800
Issuance of Capital Stock
20,479.3060
--
--
55,122.4530
12,445.0820
Free Cash Flow
-27,739.1890
-14,923.5120
-8,570.8200
-14,293.1020
-964.1310
12/31/2020 - 6/11/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALZ.ST Alzinova AB (publ)
3.4400
-3.37%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1688
+4.20%
SPRINT.ST Sprint Bioscience AB (publ)
2.0100
+4.91%
STABL.ST Stayble Therapeutics AB (publ)
0.7200
-3.36%
ONCOZ.ST OncoZenge AB (publ)
8.89
-3.47%
DIABIO.ST Diagonal Bio AB (publ)
0.0319
-4.20%
EGTX.ST Egetis Therapeutics AB (publ)
4.1000
-0.97%
KAN.ST Kancera AB (publ)
1.4460
-11.61%
BIOVIC-B.ST Biovica International AB (publ)
1.7720
-10.05%
BINV.ST BioInvent International AB (publ)
45.00
-1.10%